Hero of 3rd Annual Clinical Quality Oversight, May 21-23, 2024 | Hybrid Event, The Notary, Philadelphia

Momentum’s Clinical Quality Oversight Hybrid Event offers detailed case studies showcasing effective strategies for optimizing clinical quality across ALL involved stakeholders.

This interactive gathering of senior-level clinical quality, compliance, and operations professionals offers an opportunity to engage in-person with like-minded peers often struggling with the same challenges. Learn together through presentations, panels, roundtables, and instructional workshops, and be part of Momentum’s clinical quality community.

Kristen Hunter
VP, Content and Experience
MOMENTUM EVENTS

In-Person Experience

FULL ACCESS

Access to All Offered Content and Networking Opportunities + Option to Add-On Pre-Conference Workshops

Virtual Experience

PARTIAL ACCESS

Select Main Conference Sessions Accessible Virtually ○ NO ACCESS to Roundtable Discussions, Pre-Conference Workshops, and Sessions not Indicated as Accessible Virtually in the Agenda

2023 Testimonials

05
04
03
02
01

2023 Speaking Faculty

Leah Andrews
Leah Andrews
Former FDA Investigator; FDA Compliance Consultant

ANDREWS CONSULTANTS

Stacey Basham
Stacey Basham
Director, RDQA Supplier Lifecycle Quality

ABBVIE

Jacob Braude
Jacob Braude
Principal

ZS

Anthea Dransfield
Anthea Dransfield
Managing Director, Quality Center of Excellence

ADVARRA

David Fryrear
David Fryrear
Executive Vice President, Head of Quality Assurance

ASTELLAS

Deb Guattery
Deb Guattery
Standards and Process Lead - Decentralized Clinical Trials

PFIZER

Paul Houri
Paul Houri
Vice President, Head, BioResearch Quality Assurance

JOHNSON & JOHNSON

Anne Marie Inglis
Anne Marie Inglis
Executive Director, Clinical Operations

AFFINIVAX

Prajna Kumar, Ph.D., MPA
Prajna Kumar, Ph.D., MPA
Executive Director, Head Clinical Development and Operations Quality

ALEXION PHARMACEUTICALS

Maryann Livolsi
Maryann Livolsi
Senior Director, GCP Quality Assurance

BILL AND MELINDA GATES MEDICAL RESEARCH INSTITUTE

Dawn Lundin
Dawn Lundin
Head of Global Quality

MAPS PBC

Cheryl McCarthy, CQA, CBA, RQAP-GCP
Cheryl McCarthy, CQA, CBA, RQAP-GCP

Clinical Quality Leader;
Former Director at

IRONWOOD PHARMACEUTICALS and BIOGEN

Dawn Niccum
Dawn Niccum
Executive Vice President, QA and Compliance

INSEPTION GROUP

Jacalyn Vander Ploeg
Jacalyn Vander Ploeg
Senior Director, Culture of Quality

BMS

Jonathan Rowe
Jonathan Rowe
Principal, Head of R&D Quality, Operations and Risk Management

ZS

Leslie Sam
Leslie Sam
President

LESLIE SAM AND ASSOCIATES, LLC

Tim Stoddard
Tim Stoddard

Proactive Quality Leader
and Advisor
Previous Head of Quality

FLATIRON
Previous Clinical Quality Leader
SPARK THERAPEUTICS

Michele Weitz
Michele Weitz

Clinical Operational Excellence and Quality Consultant
GCP VISION CONSULTING
Former Executive Director, Clinical Operations Standards and Innovation
CLOVIS ONCOLOGY

Michael Wieczerzak, MS, MBA, MPH, CCRP
Michael Wieczerzak, MS, MBA, MPH, CCRP
Associate Director, Clinical Quality Management Lead

EMD SERONO

John R. Wilson, Jr., Ph.D., MPH
John R. Wilson, Jr., Ph.D., MPH
Senior Vice President

BEAUFORT

2024 SPONSORSHIP OPPORTUNITIES ARE OPEN

Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.

Thank you to our 2023 Sponsors

Logo of Advarra
Logo of InSeption Group
Logo of ZS
Logo of Beaufort

Top Reasons to Attend

Identify leading practices from the industry’s premier clinical quality experts as they candidly share innovative approaches and strategies for managing risk across the trial.

Understand the critical components of new regulatory guidance, including ICH E6 R3 and ICH E8 R1, and their impact on clinical oversight and quality risk management.

Optimize rapidly adopted remote technologies and processes to effectively oversee clinical quality.

Benchmark your clinical oversight strategy against those of similar companies to ensure you are on pace with the industry.

Integrate an effective risk-based, resource-optimizing approach for the selection, monitoring and management of clinical vendors and sites.

Ensuring your clinical vendors and sites are inspection ready with the latest tools, technologies and auditing strategies.

WHO SHOULD Attend

This event is developed for professionals from pharmaceutical, biotechnology and medical device companies, CROs, clinical service and technology providers as well as those professionals from sites who have responsibilities in any the following areas:

  • Quality Management/ Clinical Quality Management
  • Clinical Quality Assurance/ QA/ CQA
  • Clinical Quality Control/ QC/ CQC
  • Quality Operations/ Quality Systems/ Quality Processes
  • Clinical Operations/ Management/ Research/ Development
  • Compliance/ Clinical Compliance/ Regulatory Compliance
  • Auditing
  • Inspection/ Inspection Readiness
  • Clinical Outsourcing/ Vendor Oversight and Management/ Strategic Partnerships/ Third-Party Management and Oversight
  • Clinical Risk/ Quality Risk/ Risk Assessment/ Risk Management
  • Site Monitoring/ Site Management/ Study Management/ Trial Management
  • Good Clinical Practice/ GCP
  • Clinical Data
  • Regulatory Affairs